Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par offers differentiated, specialty dosage and sterile injectable drug products and is advancing a R&D pipeline of potential new products.

The recent combination of the Qualitest and Par businesses (known collectively as Par Pharmaceutical) expands Endo's generics business to a top five industry leader. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value.

Employee Rating

3.1More
TypeSubsidiary
Parent CompanyEndo International
HQChestnut Ridge, US
Founded1978
Websiteparpharm.com
Par Pharmaceutical was founded in 1978 and is headquartered in Chestnut Ridge, US

Viewing summary data as a guest

Sign up for free to see all data

Par Pharmaceutical Office Locations

Par Pharmaceutical has an office in Chestnut Ridge
Chestnut Ridge, US (HQ)
1 Ram Ridge Rd
Show all (1)

Par Pharmaceutical Financials and Metrics

Summary Metrics

Founding Date

1978

Investors

Par Pharmaceutical is a subsidiary of Endo International

Par Pharmaceutical Revenue

Par Pharmaceutical's revenue was reported to be $246.14 m in FY, 2014
Annual
USDFY, 2013FY, 2014

Revenue

1.1b246.1m

Revenue growth, %

General and administrative expense

155.2m

R&D expense

100.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015

Revenue

267.3m289.1m295.4m336.1m332.2m

General and administrative expense

39.4m50.9m43.9m42.0m54.9m

R&D expense

27.2m34.6m28.5m26.5m28.6m

Operating expense total

106.1m128.5m111.0m170.7m93.9m
Annual
USDFY, 2013FY, 2014

Cash

130.1m244.4m

Accounts Receivable

143.3m158.7m

Inventories

117.3m154.7m

Current Assets

465.6m653.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015

Cash

103.9m220.6m155.9m108.7m154.9m

Accounts Receivable

124.6m94.0m138.6m173.9m88.0m

Inventories

126.8m170.7m156.4m162.3m179.5m

Current Assets

443.2m573.7m554.6m565.2m523.1m
Annual
USDFY, 2013FY, 2014

Net Income

(105.9m)(32.5m)

Depreciation and Amortization

207.6m50.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015

Net Income

(65.8m)(39.4m)(66.3m)(103.9m)25.7m

Depreciation and Amortization

153.5m50.7m97.1m142.1m101.7m

Inventories

(14.5m)(20.3m)(23.5m)

Cash From Operating Activities

79.6m89.1m27.5m(10.2m)100.6m
Show all financial metrics

Par Pharmaceutical Frequently Asked Questions

  • When was Par Pharmaceutical founded?

    Par Pharmaceutical was founded in 1978.

  • What is Par Pharmaceutical revenue?

    Latest Par Pharmaceutical annual revenue is $246.1 m.

  • Who are Par Pharmaceutical competitors?

    Competitors of Par Pharmaceutical include Cipla, STERIS and BioScrip.

  • Where is Par Pharmaceutical headquarters?

    Par Pharmaceutical headquarters is located at 1 Ram Ridge Rd, Chestnut Ridge.

  • Where are Par Pharmaceutical offices?

    Par Pharmaceutical has an office in Chestnut Ridge.

  • How many offices does Par Pharmaceutical have?

    Par Pharmaceutical has 1 office.